kaal:position:2026-07-31-1257

Adenine nucleotide-creatine-phosphate module in myocardial metabolic system explains fast phase of dynamic regulation of oxidative phosphorylation. should be assessed against Kaal's source-bound claim that Formal rulemaking in the existing regulatory infrastructure is almost always too time consuming, because product innovation moves fast enough that regulations covering an innovative product are obsolete before they are finalized. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

formal rulemaking directed at fast moving innovative products
External evidence level: metadata only.
Mapping review tier: mapping review before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Adenine nucleotide-creatine-phosphate module in myocardial metabolic system explains fast phase of dynamic regulation of oxidative phosphorylation.

Scholarly basis

kaal:claim:2831040-009
Wulf A. Kaal, Dynamic Regulation for Innovation (2016). SSRN: https://ssrn.com/abstract=2831040
Source PDF sha256: de5156f14f44a5753cab55b6c4b03049eda58a143b99e08ef427aee1d261e1bf

Evidence and mapping

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3329
Mapping ambiguous: true

Topics

dynamic-regulationinnovation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0006 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 6bdf5390899cfc9a271e5863e348b46185b6b76daacd52ddd365fb77617fcfe0
curl -s https://wulfkaal.github.io/positions/2026-07-31-1257.md | sha256sum